Which program is designed to ensure safe isotretinoin use and pregnancy prevention?

Which program is designed to ensure safe isotretinoin use and pregnancy prevention?

• A. iPLEDGE program
• B. REMS program
• C. HIPAA protocol
• D. FDA tracking system

Answer: (A)

Isotretinoin carries a high risk of birth defects, so a strict safety program is required to prevent pregnancy and ensure proper use. The iPLEDGE program is the FDA-mandated REMS that specifically manages this risk for isotretinoin. It requires ongoing registration of patients, prescribers, and pharmacies, and it enforces pregnancy prevention through mandated contraception for those who can become pregnant along with regular pregnancy testing before and during treatment. Prescribers must verify and document these precautions, and dispensing is tightly controlled to ensure compliance and counseling. While REMS is a general category for risk mitigation, iPLEDGE is the specific program designed for isotretinoin. HIPAA governs patient privacy and does not address medication safety or pregnancy prevention, and there isn’t a separate generic FDA tracking system used for this purpose.

Isotretinoin carries a high risk of birth defects, so a strict safety program is required to prevent pregnancy and ensure proper use. The iPLEDGE program is the FDA-mandated REMS that specifically manages this risk for isotretinoin. It requires ongoing registration of patients, prescribers, and pharmacies, and it enforces pregnancy prevention through mandated contraception for those who can become pregnant along with regular pregnancy testing before and during treatment. Prescribers must verify and document these precautions, and dispensing is tightly controlled to ensure compliance and counseling.

While REMS is a general category for risk mitigation, iPLEDGE is the specific program designed for isotretinoin. HIPAA governs patient privacy and does not address medication safety or pregnancy prevention, and there isn’t a separate generic FDA tracking system used for this purpose.